Frederiksstaden Pharma ApS: Financial statements 2017
CVR: 25630483
Source: annual report 2017, Danish Business Authority
01/05/2016 – 30/04/2017
Frederiksstaden Pharma ApS (CVR 25630483) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 5,638,880 and a net result of DKK -2,380,145. Equity in the 2017 report amounted to DKK 7,297,962. The solvency ratio was 71.6%.
- Gross Profit
- DKK 5,638,880
- Profit/Loss
- DKK -2,380,145
- Equity
- DKK 7,297,962
- Total Assets
- DKK 10,197,136
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 5.6 mio. | -2.4 mio. | 7.3 mio. | - |
| 2014 | - | 3.5 mio. | -286 t. | -2.2 mio. | 14 |
| 2013 | - | 3.8 mio. | -2.3 mio. | -1.9 mio. | 14 |
| 2012 | - | 6.7 mio. | 40 t. | 426 t. | 19 |
Official annual report
Keep an eye on Frederiksstaden Pharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout Frederiksstaden Pharma ApS
Frederiksstaden Pharma ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2000. The company is registered under the industry Pakkeriaktiviteter. The company was previously named NPPHorsholm ApS and Nord Pharma Partners ApS. The management consists of Jens-Nikolaj Schøier. The company is owned by XGX Pharma ApS. The company has 2 employees (2021). In 2025, the company reported a gross profit of DKK 61,605 and a net result of DKK 139,819 compared with DKK -50,518 the year before. Equity in the 2025 report amounted to DKK 237,986.